Indocyanine green angiographic features in ocular sarcoidosis

Citation
Tj. Wolfensberger et Cp. Herbort, Indocyanine green angiographic features in ocular sarcoidosis, OPHTHALMOL, 106(2), 1999, pp. 285-289
Citations number
21
Categorie Soggetti
Optalmology,"da verificare
Journal title
OPHTHALMOLOGY
ISSN journal
01616420 → ACNP
Volume
106
Issue
2
Year of publication
1999
Pages
285 - 289
Database
ISI
SICI code
0161-6420(199902)106:2<285:IGAFIO>2.0.ZU;2-M
Abstract
Objective: To determine indocyanine green (ICG) angiographic features and e valuate the extent of choroidal involvement in proven cases of posterior oc ular sarcoidosis. Design: Nonrandomized controlled trial. Participants: Nineteen patients (14 females, 5 males; average age, 56 +/- 4 years) with clinically typical posterior sarcoidosis (biopsy-proven in 6 c ases and fulfilling the other diagnostic criteria in 13 cases) participated , with 10 control subjects (average age, 48 +/- 7 years). Criteria for the diagnosis of sarcoidosis were a positive biopsy result or the presence of a t least three of the following four criteria: elevated serum angiotensin-co nverting enzyme, elevated lysozyme, cutaneous anergy, and hilar lymph node enlargement. Intervention: Indocyanine green angiography was performed according to a st andard angiographic protocol used in inflammatory disorders. Main Outcome Measures: Indocyanine green angiographic features and proporti on of choroidal inflammatory involvement were measured. Results: Indocyanine green angiographic features could be classified into f our main patterns. The first pattern is hypofluorescent choroidal lesions i n the early and intermediate phases, irregularly distributed, invisible on funduscopy or fluorescein angiography, and localized in the midperiphery (6 3% of patients), in the macula (11%) or in both regions (26%) with an avera ge dot diameter of 0.31 +/- 0.03 disc diameters, These lesions either becam e isofluorescent in the late phase of the angiogram (Type 1, present in all patients) or remained hypofluorescent (Type 2, present in 84% of patients) , The second pattern is focal hyperfluorescent pinpoints visible in the int ermediate and late phases (in 89% of patients). The third pattern is fuzzy choroidal vessels with leakage in the intermediate phase of the angiogram, and the fourth pattern is diffuse late zonal choroidal hyperfluorescence wi th staining in the late phase of the angiogram, both features being present in all patients. Conclusions: Indocyanine green angiography allowed the authors to assess an d quantify the hitherto unknown extent of choroidal involvement in ocular s arcoidosis. Furthermore, characteristic ICG findings might represent an add itional valuable tool for diagnosing and monitoring this disease.